Tocilizumab and soluble interleukin-6 receptor in JAK2V617F somatic mutation and myeloproliferative neoplasm

Kasper Mønsted Pedersen; Yunus Çolak; Hans Carl Hasselbalch; Stig Egil Bojesen; Børge Grønne Nordestgaard

doi:10.1016/j.eclinm.2020.100337

Tocilizumab and soluble interleukin-6 receptor in JAK2V617F somatic mutation and myeloproliferative neoplasm

Kasper Mønsted Pedersen, Yunus Çolak, Hans Carl Hasselbalch, Stig Egil Bojesen, Børge Grønne Nordestgaard^*

^*Corresponding author af dette arbejde

Hæmatologisk Afdeling

Publikation: Bidrag til tidsskrift › Letter › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	100337
Tidsskrift	EClinicalMedicine
Vol/bind	22
DOI	https://doi.org/10.1016/j.eclinm.2020.100337
Status	Udgivet - maj 2020

Adgang til dokumentet

10.1016/j.eclinm.2020.100337

Citationsformater

@article{fbaddc6cc2ef45c589303ca0ad93a843,

title = "Tocilizumab and soluble interleukin-6 receptor in JAK2V617F somatic mutation and myeloproliferative neoplasm",

author = "Pedersen, {Kasper M{\o}nsted} and Yunus {\c C}olak and Hasselbalch, {Hans Carl} and Bojesen, {Stig Egil} and Nordestgaard, {B{\o}rge Gr{\o}nne}",

year = "2020",

month = may,

doi = "10.1016/j.eclinm.2020.100337",

language = "English",

volume = "22",

journal = "EClinicalMedicine",

issn = "2589-5370",

publisher = "Elsevier",

}

TY - JOUR

T1 - Tocilizumab and soluble interleukin-6 receptor in JAK2V617F somatic mutation and myeloproliferative neoplasm

AU - Pedersen, Kasper Mønsted

AU - Çolak, Yunus

AU - Hasselbalch, Hans Carl

AU - Bojesen, Stig Egil

AU - Nordestgaard, Børge Grønne

PY - 2020/5

Y1 - 2020/5

U2 - 10.1016/j.eclinm.2020.100337

DO - 10.1016/j.eclinm.2020.100337

M3 - Letter

C2 - 32395710

SN - 2589-5370

VL - 22

JO - EClinicalMedicine

JF - EClinicalMedicine

M1 - 100337

ER -